Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Achieve Life Sciences (ACHV) Change in Acquisitions & Divestments (2016 - 2026)

Achieve Life Sciences (ACHV) has disclosed Change in Acquisitions & Divestments for 12 consecutive years, with $15.4 million as the latest value for Q1 2026.

  • Quarterly Change in Acquisitions & Divestments rose 4.87% to $15.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $31.6 million through Mar 2026, up 15.42% year-over-year, with the annual reading at $30.9 million for FY2025, 17.33% up from the prior year.
  • Change in Acquisitions & Divestments for Q1 2026 was $15.4 million at Achieve Life Sciences, up from $5.8 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $15.4 million in Q1 2026, with the low at $2.8 million in Q3 2025.
  • Average Change in Acquisitions & Divestments over 3 years is $9.8 million, with a median of $10.1 million recorded in 2024.
  • The sharpest move saw Change in Acquisitions & Divestments crashed 54.14% in 2025, then grew 4.87% in 2026.
  • Achieve Life Sciences' Change in Acquisitions & Divestments stood at $12.6 million in 2024, then crashed by 54.14% to $5.8 million in 2025, then surged by 166.07% to $15.4 million in 2026.
  • Per Business Quant, the three most recent readings for ACHV's Change in Acquisitions & Divestments are $15.4 million (Q1 2026), $5.8 million (Q4 2025), and $2.8 million (Q3 2025).